Biological Mechanisms in Symptom Clustering: Insights from Genomic and Proteomic

Dear Colleagues,

This Special Issue of Biomedicines, entitled "Biological Mechanisms in Symptom Clustering: Insights from Genomic and Proteomic", highlights the importance of understanding the underlying biological mechanisms behind symptom clustering. This topic has gained significant attention in recent years due to its potential implications for personalized medicine and improving patient outcomes.

The biological mechanisms in the clustering of symptoms refer to the underlying physiological processes that contribute to the occurrence and co-occurrence of multiple symptoms in various medical conditions. These mechanisms involve intricate interactions between different systems within the human body, such as the nervous system, immune system, endocrine system, and genetic factors. By studying genomic and proteomic markers, researchers aim to uncover the molecular basis of these clusters, which can provide valuable insights into disease progression, treatment response, and prognosis.

Genomics involves analyzing an individual's genetic material (DNA) to identify variations or mutations that may contribute to symptom clustering. Through techniques such as genome-wide association studies (GWAS), scientists can pinpoint specific genes or regions of DNA associated with particular symptom combinations. This knowledge not only enhances our understanding of disease pathogenesis but also opens up possibilities for targeted therapies tailored to an individual's genetic profile.

Proteomics complements genomics by focusing on the study of proteins—the functional units encoded by genes—within cells, tissues, or bodily fluids. By examining protein expression patterns using advanced technologies such as mass spectrometry or protein microarrays, researchers can identify biomarkers associated with specific symptom clusters. These biomarkers have great potential for early detection and diagnosis in various diseases.

In conclusion, exploring the intricate web of biological mechanisms underlying symptom clustering provides valuable insights into disease pathogenesis and offers potential avenues for improving patient care through more precise diagnostic tools and therapeutic interventions.

Dr. Nada Lukkahatai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• biomarkers
• biological pathways
• biological mechanisms
• symptoms clusters
• co-occurrent symptoms